Fosun International’s Teva Pharmaceuticals TEVA Stock Holding History

Fosun International’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-45,000	Closed	-$398K	–	210
2020 Q3	$398K	Sell	45,000 -34,000	-43%	-$360K	0.04%	136
2020 Q2	$971K	Sell	79,000 -83,000	-51%	-$939K	0.09%	86
2020 Q1	$1.38M	Buy	162,000 +72,000	+80%	+$738K	0.13%	72
2019 Q4	$896K	Hold	90,000	–	–	0.07%	122
2019 Q3	$622K	Buy	90,000 +5,000	+6%	+$38.3K	0.07%	142
2019 Q2	$771K	Buy	85,000 +37,000	+77%	+$446K	0.05%	194
2019 Q1	$746K	Buy	48,000 +5,000	+12%	+$88.2K	0.05%	187
2018 Q4	$666K	Hold	43,000	–	–	0.04%	184
2018 Q3	$909K	Buy	43,000 +11,500	+37%	+$267K	0.04%	148
2018 Q2	$766K	Buy	+31,500	New	+$642K	0.04%	75
2018 Q1	–	Sell	-31,500	Closed	-$597K	–	74
2017 Q4	$597K	Buy	+31,500	New	+$474K	0.05%	55

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Fosun International's TEVA Position: Q4 2020 in Review

Fosun International sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 45,000 shares — an estimated $398K sold.

Fosun International first reported a position in TEVA in Q4 2017 and held it in 11 quarters. The position peaked at $1.38M in Q1 2020. 449 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

Fosun International reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Fosun International sold 45,000 Teva Pharmaceuticals shares in Q4 2020, an estimated $398K.
Fosun International first reported a position in Teva Pharmaceuticals in Q4 2017 and held it in 11 quarters.
Fosun International's Teva Pharmaceuticals position peaked at $1.38M in Q1 2020.
449 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Fosun International's 13F filing for Q4 2020, filed 5 Feb 2021.